Analysts Have Conflicting Sentiments on These Healthcare Companies: Compass Therapeutics (CMPX), Innate Pharma (IPHA) and Sanofi (OtherSNYNF)
at www.tipranks.com (Mon, 9-Nov 6:50 AM)
Buy Rating Reaffirmed as IPH4502, PACIFIC-9, and Lacutamab Catalysts Support Unchanged $9 Price Target
at www.tipranks.com (Fri, 6-Nov 9:04 AM)
